Around 4,400 representatives of approximately 2,300 biotechnology companies from over 60 countries are expected at the 25th Bio-Europe congress in Hamburg’s Messehallen from November 11-13, 2019. The leading conference for biotechnology outside of the United States will focus on visions for the future over the next 25 years and will look back on its history. Hamburg will host Bio-Europe for the third time along with the state of Schleswig-Holstein and Life Science Nord.
Organizers expect biggest Bio-Europe ever
“In Hamburg, everything revolves around connecting with each other. No other city in Europe has as many bridges as Hamburg. In keeping with this great tradition, Life Science Nord connects 500 companies, research institutions and institutions to create an innovative and practical community”, said Hinrich Habeck, Managing Director of Life Science Nord. Bio-Europe is one of the most important events for biotechnology firms, as it provides immediate access to service and manufacturing partners as well as innovative ideas.
The organizers, EBD Group, are expecting this year’s congress to be the largest ever. Experts will present the latest innovations, for instance, in women’s health and digital medicine. Topics on the agenda are likely to include gene therapy evaluation and how smaller biotech companies can enter the European market and link up with moversa and shakers in the sector.